Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways

Citations Over TimeTop 1% of 2015 papers

Abstract

Amyotrophic lateral sclerosis (ALS) is a devastating neurological disease with no effective treatment. We report the results of a moderate-scale sequencing study aimed at increasing the number of genes known to contribute to predisposition for ALS. We performed whole-exome sequencing of 2869 ALS patients and 6405 controls. Several known ALS genes were found to be associated, and TBK1 (the gene encoding TANK-binding kinase 1) was identified as an ALS gene. TBK1 is known to bind to and phosphorylate a number of proteins involved in innate immunity and autophagy, including optineurin (OPTN) and p62 (SQSTM1/sequestosome), both of which have also been implicated in ALS. These observations reveal a key role of the autophagic pathway in ALS and suggest specific targets for therapeutic intervention.

Related Papers

• → Polyubiquitin Binding to Optineurin Is Required for Optimal Activation of TANK-binding Kinase 1 and Production of Interferon β(2011)169 cited
• → Structural insights into the interaction and disease mechanism of neurodegenerative disease-associated optineurin and TBK1 proteins(2016)128 cited
• → Identification of TBK1 complexes required for the phosphorylation of IRF3 and the production of interferon β(2017)62 cited
• → The Role of Optineurin in Antiviral Type I Interferon Production(2018)26 cited
• → TDP-43 subcellular mislocalisation is correlated with loss of optineurin binding for frontotemporal dementia and amyotrophic lateral sclerosis associated TBK1 missense variants(2022)